{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:44:43Z","timestamp":1790649883013,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001077","name":"Royal Brisbane and Women's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10620-018-5357-0","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T07:35:37Z","timestamp":1543217737000},"page":"503-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn\u2019s Disease"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6804-1752","authenticated-orcid":false,"given":"James R.","family":"Irwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Doecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daman","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Arnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Radford-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"5357_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/00365528909091339","volume":"170","author":"JE Lennard-Jones","year":"1989","unstructured":"Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2\u20136.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"5357_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","volume":"4","author":"G Assche Van","year":"2010","unstructured":"Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: Definitions and diagnosis. J Crohns Colitis. 2010;4:7\u201327. \n                    https:\/\/doi.org\/10.1016\/j.crohns.2009.12.003\n                    \n                  .","journal-title":"J Crohns Colitis"},{"key":"5357_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","volume":"4","author":"A Dignass","year":"2010","unstructured":"Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: Current management. J Crohns Colitis. 2010;4:28\u201362. \n                    https:\/\/doi.org\/10.1016\/j.crohns.2009.12.002\n                    \n                  .","journal-title":"J Crohns Colitis"},{"key":"5357_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0016-5107(83)72583-6","volume":"29","author":"FJ Tedesco","year":"1983","unstructured":"Tedesco FJ, Hardin RD, Harper RN, Edwards BH. Infectious colitis endoscopically simulating inflammatory bowel disease: A prospective evaluation. Gastrointest Endosc. 1983;29:195\u2013197.","journal-title":"Gastrointest Endosc"},{"key":"5357_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/00365529409090475","volume":"29","author":"G Schumacher","year":"1994","unstructured":"Schumacher G, Sandstedt B, Kollberg B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Clinical findings and early diagnosis. Scand J Gastroenterol. 1994;29:265\u2013274.","journal-title":"Scand J Gastroenterol"},{"key":"5357_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/ibd.21719","volume":"18","author":"SR Vavricka","year":"2012","unstructured":"Vavricka SR, Spigaglia SM, Rogler G, et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:496\u2013505. \n                    https:\/\/doi.org\/10.1002\/ibd.21719\n                    \n                  .","journal-title":"Inflamm Bowel Dis"},{"key":"5357_CR7","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1097\/MIB.0000000000001257","volume":"23","author":"VQ Nguyen","year":"2017","unstructured":"Nguyen VQ, Jiang D, Hoffman SN, et al. Impact of diagnostic delay and associated factors on clinical outcomes in a U.S. inflammatory bowel disease Cohort. Inflamm Bowel Dis. 2017;23:1825\u20131831. \n                    https:\/\/doi.org\/10.1097\/mib.0000000000001257\n                    \n                  .","journal-title":"Inflamm Bowel Dis"},{"key":"5357_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MIB.0000000000000612","volume":"22","author":"D Sorrentino","year":"2016","unstructured":"Sorrentino D. Preclinical and undiagnosed Crohn\u2019s disease: The submerged Iceberg. Inflamm Bowel Dis. 2016;22:476\u2013486. \n                    https:\/\/doi.org\/10.1097\/MIB.0000000000000612\n                    \n                  .","journal-title":"Inflamm Bowel Dis"},{"key":"5357_CR9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/apt.13641","volume":"43","author":"RS Choung","year":"2016","unstructured":"Choung RS, Princen F, Stockfisch TP, et al. Serologic microbial associated markers can predict Crohn\u2019s disease behaviour years before disease diagnosis. Aliment Pharmacol Ther. 2016;43:1300\u20131310. \n                    https:\/\/doi.org\/10.1111\/apt.13641\n                    \n                  .","journal-title":"Aliment Pharmacol Ther"},{"key":"5357_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gut.2003.030734","volume":"53","author":"DG Forcione","year":"2004","unstructured":"Forcione DG, Rosen MJ, Kisiel JB, Sands BE. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn\u2019s disease. Gut. 2004;53:1117\u20131122. \n                    https:\/\/doi.org\/10.1136\/gut.2003.030734\n                    \n                  .","journal-title":"Gut"},{"key":"5357_CR11","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/gut.2004.060228","volume":"54","author":"E Israeli","year":"2005","unstructured":"Israeli E, Grotto I, Gilburd B, et al. Anti-saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005;54:1232\u20131236. \n                    https:\/\/doi.org\/10.1136\/gut.2004.060228\n                    \n                  .","journal-title":"Gut"},{"key":"5357_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cgh.2016.01.016","volume":"14","author":"P Lochhead","year":"2016","unstructured":"Lochhead P, Khalili H, Ananthakrishnan AN, Richter JM, Chan AT. Association between circulating levels of C-reactive protein and Interleukin-6 and risk of inflammatory bowel disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2016;14:818\u2013824.e6. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2016.01.016\n                    \n                  .","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"5357_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/art.24350","volume":"60","author":"EW Karlson","year":"2009","unstructured":"Karlson EW, Chibnik LB, Tworoger SS, et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum. 2009;60:641\u2013652. \n                    https:\/\/doi.org\/10.1002\/art.24350\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"5357_CR14","first-page":"1282","volume":"18","author":"K Aho","year":"1991","unstructured":"Aho K, Heli\u00f6vaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol. 1991;18:1282\u20131284.","journal-title":"J Rheumatol"},{"key":"5357_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/art.1780311004","volume":"31","author":"A Puente del","year":"1988","unstructured":"del Puente A, Knowler WC, Pettitt DJ, Bennett PH. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum. 1988;31:1239\u20131244.","journal-title":"Arthritis Rheum"},{"key":"5357_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/ard.51.7.863","volume":"51","author":"T J\u00f3nsson","year":"1992","unstructured":"J\u00f3nsson T, Thorsteinsson J, Kolbeinsson A, J\u00f3nasd\u00f3ttir E, Sigf\u00fasson N, Valdimarsson H. Population study of the importance of rheumatoid factor isotypes in adults. Ann Rheum Dis. 1992;51:863\u2013868.","journal-title":"Ann Rheum Dis"},{"key":"5357_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/jaut.1996.0051","volume":"9","author":"CF Verge","year":"1996","unstructured":"Verge CF, Gianani R, Kawasaki E, et al. Number of autoantibodies (against insulin, GAD or ICA512\/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun. 1996;9:379\u2013383.","journal-title":"J Autoimmun"},{"key":"5357_CR18","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing, R version 3.4.4. Vienna, Austria: R Foundation for Statistical Computing; 2018. \n                    https:\/\/www.R-project.org\/\n                    \n                  . Accessed 12 Nov 2018."},{"key":"5357_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v014.i06","volume":"14","author":"A Zeileis","year":"2005","unstructured":"Zeileis A, Grothendieck G. zoo: S3 Infrastructure for regular and irregular time series. J Stat Softw. 2005;14:1\u201327. \n                    https:\/\/doi.org\/10.18637\/jss.v014.i06\n                    \n                  .","journal-title":"J Stat Softw"},{"key":"5357_CR20","unstructured":"Champely S. PWR: Basic Functions for Power Analysis, R package version 1.2-1; 2017. \n                    https:\/\/CRAN.R-project.org\/package=pwr\n                    \n                  . Accessed 12 Nov 2018."},{"key":"5357_CR21","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale: L. Erlbaum Associates; 1988."},{"key":"5357_CR22","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1572-0241.2001.03755.x","volume":"96","author":"MJ Wagtmans","year":"2001","unstructured":"Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Gender-related differences in the clinical course of Crohn\u2019s disease. Am J Gastroenterol. 2001;96:1541\u20131546. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03755.x\n                    \n                  .","journal-title":"Am J Gastroenterol"},{"key":"5357_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/00365521.2010.533382","volume":"46","author":"P Bager","year":"2011","unstructured":"Bager P, Befrits R, Wikman O, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46:304\u2013309. \n                    https:\/\/doi.org\/10.3109\/00365521.2010.533382\n                    \n                  .","journal-title":"Scand J Gastroenterol"},{"key":"5357_CR24","unstructured":"OECD Statistics. \n                    http:\/\/stats.oecd.org\/\n                    \n                  . Accessed June 20, 2017."},{"key":"5357_CR25","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1136\/annrheumdis-2013-204867","volume":"74","author":"J S\u00f8rensen","year":"2015","unstructured":"S\u00f8rensen J, Hetland ML. Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: Results from the Danish nationwide DANBIO registry. Ann Rheum Dis. 2015;74:e12. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204867\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"5357_CR26","unstructured":"Inflammatory bowel disease|Guidance and guidelines|NICE. \n                    https:\/\/www.nice.org.uk\/guidance\/qs81\n                    \n                  . Accessed June 21, 2016."},{"key":"5357_CR27","unstructured":"English|World Gastroenterology Organisation. \n                    http:\/\/www.worldgastroenterology.org\/guidelines\/global-guidelines\/inflammatory-bowel-disease-ibd\/inflammatory-bowel-disease-ibd-english\n                    \n                  . Accessed June 21, 2016."},{"key":"5357_CR28","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785\u20131794. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2011.01.055\n                    \n                  .","journal-title":"Gastroenterology"},{"key":"5357_CR29","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.3748\/wjg.v12.i44.7097","volume":"12","author":"G Radford-Smith","year":"2006","unstructured":"Radford-Smith G, Pandeya N. Associations between NOD2\/CARD15 genotype and phenotype in Crohn\u2019s disease-Are we there yet? World J Gastroenterol WJG. 2006;12:7097\u20137103. \n                    https:\/\/doi.org\/10.3748\/wjg.v12.i44.7097\n                    \n                  .","journal-title":"World J Gastroenterol WJG"},{"key":"5357_CR30","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/ajg.2012.196","volume":"107","author":"LM Higuchi","year":"2012","unstructured":"Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107:1399\u20131406. \n                    https:\/\/doi.org\/10.1038\/ajg.2012.196\n                    \n                  .","journal-title":"Am J Gastroenterol"},{"key":"5357_CR31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/ajcn\/80.5.1342","volume":"80","author":"E Klement","year":"2004","unstructured":"Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342\u20131352.","journal-title":"Am J Clin Nutr"},{"key":"5357_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1440-1746.2009.06140.x","volume":"25","author":"RB Gearry","year":"2010","unstructured":"Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325\u2013333. \n                    https:\/\/doi.org\/10.1111\/j.1440-1746.2009.06140.x\n                    \n                  .","journal-title":"J Gastroenterol Hepatol"},{"key":"5357_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/gut.51.6.808","volume":"51","author":"GL Radford-Smith","year":"2002","unstructured":"Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn\u2019s disease. Gut. 2002;51:808\u2013813.","journal-title":"Gut"},{"key":"5357_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/00365520801971736","volume":"43","author":"H Hildebrand","year":"2008","unstructured":"Hildebrand H, Malmborg P, Askling J, Ekbom A, Montgomery SM. Early-life exposures associated with antibiotic use and risk of subsequent Crohn\u2019s disease. Scand J Gastroenterol. 2008;43:961\u2013966.","journal-title":"Scand J Gastroenterol"},{"key":"5357_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.eururo.2006.12.017","volume":"52","author":"D Connolly","year":"2007","unstructured":"Connolly D, Black A, Murray LJ, Napolitano G, Gavin A, Keane PF. Methods of calculating prostate-specific antigen velocity. Eur Urol. 2007;52:1044\u20131050. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2006.12.017\n                    \n                  .","journal-title":"Eur Urol"},{"key":"5357_CR36","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2337\/dc11-1793","volume":"35","author":"Y Heianza","year":"2012","unstructured":"Heianza Y, Arase Y, Fujihara K, et al. Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: The Toranomon Hospital Health Management Center Study 7 (TOPICS 7). Diabetes Care. 2012;35:1050\u20131052. \n                    https:\/\/doi.org\/10.2337\/dc11-1793\n                    \n                  .","journal-title":"Diabetes Care"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5357-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:07:40Z","timestamp":1574708860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5357-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5357"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5357-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"GRS has worked on advisory boards for and received consulting fees from Abbvie, Janssen, Ferring, Takeda, and Amgen. JRI, EF, KH, LAS, JD, DL, and AA have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}